Monday, September 2, 2002

‘Avian Influenza’ Provides Overview of Several Categories of Anti-Influenza Technology Platforms That Are Revolutionizing Flu Related Healthcare in Hospitals

‘Avian Influenza’ Provides Overview of Several Categories of Anti-Influenza Technology Platforms That Are Revolutionizing Flu Related Healthcare in Hospitals

Research and Markets (http://www. researchandmarkets. com/reports/c43034) has announced the addition of Trimark Publication’s Avian Influenza: The Threatening Pandemic to their offering.

Dublin (PRWEB) October 5, 2006

Research and Markets (http://www. researchandmarkets. com/reports/c43034 (http://www. researchandmarkets. com/reports/c43034)) has announced the addition of Trimark Publication’s Avian Influenza: The Threatening Pandemic to their offering.

The purpose of this report is to describe the threatening world pandemic caused by avian influenza, also known as bird flu. This report discusses the origins of the disease, the bird-to-human infection risks, the catastrophic health crisis avian flu poses, and the efforts by world governments and international health organizations to mitigate the impact of the threat to humans.

Influenza, commonly known as the flu, is an infectious disease that infects birds and mammals (primarily of the upper airways and lungs in mammals) and is caused by an RNA virus. Flu rapidly spreads around the world in seasonal epidemics, killing millions of people in pandemic years and hundreds of thousands in non-pandemic years. Three influenza pandemics in the 20th century—each following a major genetic change in the virus—killed millions of people all over the world. The world’s current major influenza pandemic threat is H5N1, but it is at present mostly in birds and not in people. The specific objectives of this analysis are to:

Examine the epidemiology of avian influenza. Describe the diagnosis and treatments available for influenza. Discuss preparedness for a worldwide pandemic. Evaluate the world economic impact of an influenza epidemic.

The goal is to review the potential threat of a human influenza pandemic resulting from the avian flu virus and define the responses that are now being undertaken worldwide by governmental authorities to contain the spreading bird flu. Specifically, this study contains:

A comprehensive overview of the several categories of anti-influenza technology platforms that are or will be revolutionizing flu related healthcare in hospitals. Full descriptions of the public health measures involved in controlling the spread of avian influenza and the prevention of cross infection to humans. Analysis of the technological approaches undertaken by various world governments, as well as industry and end-user response to these ideas. Regulatory issues and legislation affecting use and marketing of influenza prevention and treatment products. Forecasts for each category of infection control.

This analysis will allow the reader to:

Evaluate the effect of strategic factors and technology driven measures for controlling avian flu and subsequent human infections. Investigate how cost-constraints and technological advances are driving change in the influenza market. Examine the structure of the avian flu response across the world and learn how to respond successfully to this challenge to human health. Assess the growth opportunities in all influenza-related treatments and preventative measures. Review the main approaches in each sector and plan a strategy in line with the strengths and weaknesses of the infection control measures.

Chapter Titles Include:

1. Overview

2. Introduction and Executive Summary

3. The Basics of Human Influenza

4. The Basics of Avian Influenza

5. Epidemiology of Avian Influenza

6. Influenza Diagnosis & Laboratory Issues

7. Preparedness

8. Economics of Avian Influenza

9. Fighting the Flu

List of Tables

For more information visit http://www. researchandmarkets. com/reports/c43034 (http://www. researchandmarkets. com/reports/c43034)

Source: Trimark Publications

Laura Wood

Senior Manager

Research and Markets

Fax: +353 1 684 99 77

###